Health ❯ Pharmaceuticals

Drug Safety

Contaminated Drugs Contaminated Products Quality Control Contamination Adulteration Regulatory Actions Toxicology Adverse Effects Counterfeit Drugs Recalls Fentanyl FDA Regulations Toxic Substances Cough Syrups Regulation Regulations Regulatory Compliance Mifepristone Acetaminophen Contaminants Side Effects Contaminated Medications Clinical Trials Regulatory Affairs Cough Syrup Abortion Drugs Drug Recalls Counterfeit Medications Legal Issues Medication Recall Regulatory Issues Abortion Pills Manufacturing Practices Product Recalls GLP-1 Drugs Contaminated Substances Cancer Risk Contraceptives Carcinogens Health Risks FDA Approval Adverse Events Hormonal Therapies Contamination Issues Mental Health Adulterated Products Pregnancy Health Contaminated Medicines Pregnancy Risks Acetaminophen Risks Chemical Abortion Prenatal Health Manufacturing Standards Cancer Risks Lawsuits Regulatory Agencies Paracetamol Weight Loss Medications Public Perception Controlled Substances Product Tampering Spurious Medicines Antidepressants Unauthorized Medications Compounded Drugs Anticholinergic Drugs Ivermectin Adulterated Drugs Accountability Psychiatric Side Effects Tylenol Pregnancy Medications Medical Negligence Paediatric Medicine Regulatory Bodies Compliance Potency Drugs Alternative Treatments Compounded Medications Expired Drugs Adverse Reactions Zantac Cyanide Poisoning GLP-1 Receptor Agonists Quality Assurance Chlorine Dioxide Illicit Drugs Chirality in Drugs Toxicity Painkillers Organ Damage Diethylstilbestrol Drug Importation Consumer Health Products Counterfeit Medicines Prescription Medications Medication Traceability Consumer Warnings Manufacturing Inspections Diethylstilbestrol (DES)

EMA Panel Recommends EU Withdrawal of Levamisole Over Rare Brain Risk

An EU safety review found unpredictable cases of leukoencephalopathy after even one dose, shifting the drug’s benefit–risk balance to negative.

GLP-1 Weight-Loss Push Intensifies as Novo Leads Ads and Wegovy Pill Drives Telehealth Uptake

Gold Star Recalls Nearly 2,000 Products After FDA Finds Rodent and Bird Contamination

AstraZeneca Withdraws Andexxa From U.S. Market After FDA Says Risks Outweigh Benefits

FDA Adds Brain Tumor Warning to Two Depo‑Provera Injections

Sanofi Ends PPMS Bid After Tolebrutinib Fails Phase 3 as FDA Delays Review for nrSPMS

Sen. Ron Johnson Endorses Book Promoting Chlorine Dioxide as Treatment

FDA Class III Recall Targets 11,136 Bottles of Ziac Over Trace Ezetimibe Contamination

Hawley Pressures FDA Chief as Anti‑Abortion Groups Demand Firing Over Reported Mifepristone Review Delay

WHO Endorses GLP‑1s for Obesity as Australia Adds Class‑Wide Mental Health Warning

Appeals Court Weighs Revival of Tylenol–Autism Cases as Texas Judge Rejects Paxton’s Requests

Florida Sues Planned Parenthood Over ‘Safer Than Tylenol’ Abortion Pill Claim, Seeks $350 Million

Paxton Moves to Block Kenvue’s $400 Million Dividend, Seeks Curbs on Tylenol Ads

FDA Class II Recall Targets 580,000 Prazosin Bottles for Nitrosamine Overages

Texas Sues J&J and Kenvue Over Tylenol Marketing to Pregnant Women, Citing Autism Risk

FDA Lists Class II Recall of 141,984 Bottles of Generic Atorvastatin

Ascend Recalls 141,984 Bottles of Generic Atorvastatin Over Dissolution Failures

India Cough Syrup Crisis: Sresan Pharma Owner Detained as Tamil Nadu Confirms Toxic Contamination

FDA Reviews Tylenol Label as WHO Rejects Claims of Prenatal Link to Autism

FDA Opens Mifepristone Safety Review as Republicans Move to Curb Mail and Telehealth Access